Effect of HLA matching on cadaver kidney function: experience at a single large center.
Whenever the results are compared within a given time period, within a given age group, within the nondiabetic population, and within groups receiving high or low doses of ALG, the advantages of well-matched kidneys continually and significantly demonstrate themselves. Tissue matching failed to improve survival and function only in diabetic patients who frequently die of problems unrelated to rejection. The results thus demonstrate an overall clear superiority in patient survival and transplant function of the better-matched kidneys.
D002102:Cadaver; D048909:Diabetes Complications; D006085:Graft Survival; D006680:HLA Antigens; D006649:Histocompatibility Antigens; D006650:Histocompatibility Testing; D006801:Humans; D007668:Kidney / Q000502:physiology; D016030:Kidney Transplantation; D009026:Mortality; D013997:Time Factors; D014184:Transplantation, Homologous
D006680:HLA Antigens; D006649:Histocompatibility Antigens